Sick Roundup users will receive between $10,000 and $165,000 each.

The class also binds people who fall ill later, capping Bayer’s exposure for up to 21 years.

Bayer pays $7.25bn into a fund, and each award depends on use, diagnosis date and severity.

Some attorneys objected the fund is too small, but Judge Timothy Boyer said he would not delay payouts to sick victims.

Bayer, which denies Roundup causes non-Hodgkin lymphoma, had set itself a year-end target to contain the litigation.

How each outlet framed it

drawn from 70+ reports worldwide

Financial Times News
frames the ruling mainly as Bayer's balance-sheet relief, tracing the share price doubling to its legislative lobbying for pesticide liability laws
BBC
details the payout structure, $10,000 to $165,000 per claimant over up to 21 years, and the Supreme Court 7-2 ruling that preceded the settlement

Sources: Financial Times News, BBC